| Autor: |
Crowther, C.A., Ashwood, P., Middleton, P.F., McPhee, A., Tran, T., Harding, J.E. |
| Zdroj: |
Obstetric Anesthesia Digest; June 2024, Vol. 44 Issue: 2 p94-94, 1p |
| Abstrakt: |
(JAMA. 2023;330(7):603–614)Preterm infants have a greater risk of cerebral palsy, a common motor disability for which there is no cure. As such, primary prevention is especially important. The use of magnesium sulfate while pregnant has been shown in randomized clinical trials to be helpful for those at risk of early preterm delivery by improving an infant’s chance of survival without cerebral palsy. As a result, magnesium sulfate is recommended for fetal neuroprotection. However, there is a lack of data surrounding the ideal gestational age for using it prenatally. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
